Evidence map›Paper›PMID 32789236›Full record

ArticleProgress in rehabilitation medicine2018

Systemic Inflammation in the Recovery Stage of Stroke: Its Association with Sarcopenia and Poor Functional Rehabilitation Outcomes.

Yoshihiro Yoshimura, Takahiro Bise, Fumihiko Nagano, Sayuri Shimazu, Ai Shiraishi, Makio Yamaga, Hiroaki Koga

Open access · diamondAbstract read
In one paragraph

Article in Progress in rehabilitation medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Prevalence of Stroke-Related Sarcopenia: A Systematic Review and Meta-Analysis.Physiotherapy research international : the journal for researchers and clinicians in physical therapy · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Observational
  6. Article
  7. Observational
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Aging after stroke: how to define post-stroke sarcopenia and what are its risk factors?European journal of physical and rehabilitation medicine · 2022
    Observational
  19. Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus.The review of diabetic studies : RDS · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yoshihiro YoshimuraDepartment of Rehabilitation Medicine, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Takahiro BiseDepartment of Rehabilitation, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Fumihiko NaganoDepartment of Rehabilitation, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Sayuri ShimazuDepartment of Nutritional Management, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Ai ShiraishiDepartment of Dental Office, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Makio YamagaDepartment of Rehabilitation Medicine, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Hiroaki KogaDepartment of Rehabilitation Medicine, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Kumamoto Orthopedic Surgery Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of our study was to investigate how systemic inflammation relates to sarcopenia and its impact on functional outcomes in the recovery stages of stroke.

methodsA retrospective cohort study was performed in consecutive patients admitted to convalescent rehabilitation wards following stroke. Patients with acute or chronic high-grade inflammatory diseases were excluded. Systemic inflammation was evaluated using the modified Glasgow Prognostic Score (mGPS). Sarcopenia was defined as a loss of skeletal muscle mass and decreased muscle strength, with the cut-off values set by the Asian Working Group for Sarcopenia. The primary outcome was the motor domain of the Functional Independence Measure (FIM-motor). Univariate and multivariate analyses were used to determine whether mGPS was associated with sarcopenia and FIM-motor at discharge.

resultsThe study included 204 patients (mean age 74.1 years, 109 men). mGPS scores of 0, 1, and 2 were assigned to 149 (73.0%), 40 (19.6%), and 13 (6.4%) patients, respectively. Sarcopenia was diagnosed in 81 (39.7%) patients and was independently associated with stroke history (odds ratio [OR] 1.890, P=0.027), premorbid modified Rankin scale (OR 1.520, P=0.040), body mass index (OR 0.858, P=0.022), and mGPS score (OR 1.380, P=0.021). Furthermore, the mGPS score was independently associated with sarcopenia (OR 1.380, P=0.021) and FIM-motor at discharge (β=-0.131, P=0.031).

conclusionSystemic inflammation is closely associated with sarcopenia and poor functional outcomes in the recovery stage of stroke. Early detection of systemic inflammation and sarcopenia can help promote both adequate exercise and nutritional support to restore muscle mass and improve post-stroke functional recovery.

Indexed as

nutritionrehabilitationsarcopeniastrokesystemic inflammation

Identifiers

PMID32789236
PMCPMC7365223
OpenAlexW2803865822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.